1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends

G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

  • August 2014
  • 508 pages
  • BCC Research
Report ID: 2313351

Summary

Table of Contents

This report elaborates on the present landscape for major segments of the GPCR drug market, discusses and relates the future trends and strategies to the breakthrough developments within the market. The estimations for the period between 2013 and 2018 are applied on the sales figures for the global and regional market forecasting.

Use this report to:
- Gain in detail information about the GPCR market by disease type as well as by drug group.
- Analyze prospects in the pipeline for GPCR targeting drugs.
- Learn about the key drivers and limiting factors as well as major threats versus opportunities for the future growth and direction of the GPCR market.

Highlights
- The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, BCC Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.
- The US market was $48.1 billion in 2012. This market is predicted to decrease to $44.5 billion by 2013. With a CAGR of 2.0% from 2013 to 2018, it is expected that the market would recover and reach $49.1 billion by 2018.
- The BRIC market achieved a positive CAGR during the previous three years and increased its market share to nearly $8 billion by 2013. With a CAGR of 5.4% from 2013 to 2018, BCC Research estimates this market to reach $10.3 billion by 2018.

Introduction & Scope
INTRODUCTION
STUDY OBJECTIVES
The aim of this work is to study the global market for G Protein Coupled Receptor, or GPCR-targeting drugs, and to provide beneficial information on the current and future
participators that determine the market’s short-term directions.

This report elaborates on the present landscape for major segments of the GPCR drug market, which includes three extensive sets of drug groups under Class A, B and C
GPCR-targeting drugs; and furthermore, the report discusses and relates the future trends and strategies to the breakthrough developments within the market. The key drivers and limiting factors as well as major threats versus opportunities for the future growth and direction of the market were identified and addressed within this
report. The classification and comparison of the distinct segments of the GPCR drugs were performed and conveyed via the report, along with the anticipated extensions to
these segments.

The industry dynamics and characteristics were analyzed and utilized for the interpretation and forecasting for the overall GPCR drugs. The obtained revenues for the majority of the indicated products constituting the market were collected and broken down by region. The estimations for the period between 2013 and 2018 were applied on the sales figures for the global and regional market forecasting. The report also sheds light on the therapeutic applications of the marketed GPCR drugs; the breakdown by therapeutic applications was accomplished under eight main groups and multiple subgroups. The regulatory views on the marketed and in-development products were also mentioned through the recent approvals and enforced safety measures for the product manufacturers.

REASONS FOR DOING THE STUDY
The recent technological advances and accumulating structural and functional literature on the physiological and pharmacological features of the GPCRs have shown that these targets have versatile utilities in the treatment of a broad spectrum of diseases across almost every therapeutic area. The multitude of the untapped orphan GPCR targets and the previously undruggable targets that are becoming viable just recently attracted companies from various backgrounds of specialties and expertise to invest more in the research and development of the GPCR drugs.

Innovation and improvement are the offsetting factors for the effects of the ongoing patent expirations and concentrated regression of market sub-segments following peak
years of sales. The innovations under existing and newly appearing market segments were provided in the report; trends for improvement and seizable market opportunities
were mentioned under therapeutic applications.

INTENDED AUDIENCE
This study adds value to the processes of the discovery, development and commercialization of the GPCR-targeting drugs. Pharmaceutical and biotechnology companies, research institutes and healthcare professionals, large companies and small to medium-size enterprises will find this report to be of great utility.

SCOPE OF THE STUDY
The scope of this study encompasses the GPCR targeting drugs in pharmaceutical and biopharmaceutical markets. BCC Research analyzed each market and its applications,
regulatory environment, technology, market projections and market share. Technological issues include the latest trends and developments. The strong growing market for the GPCR drugs includes the countries of the EU such as the U.K., France, Germany, Spain and Italy, and also include the emerging countries such as China, Brazil, South Korea, Taiwan, Mexico and other countries.

METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research were conducted and used in preparing this study. The analyst of the report conducted a comprehensive literature search from public,
private and government sources, which included company publications, industrial and market reports available in physical or electronic format, research papers, scientific
journals and various other professionally written dedicated sources; as well as industrial databases, company and product literature.

Data were obtained through interviews and correspondence with the research-based companies and technical experts of the GPCR-based drug lead discovery. Projections were based on estimates such as the current number of end users, potential end users, market entry products, patent expirations, regional dynamics, disease prevalence and other market trends.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • July 2017
  • by MarketsandMarkets

“Cell-based assays market projected to grow at a CAGR of 8.4% during the forecast period” The global cell-based assays market is expected to reach USD 19.92 billion by 2022, at a CAGR of 8.4% from ...

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

  • $ 5501
  • Industry report
  • June 2017
  • by BCC Research

• The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in ...

2017 Norway Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 4500
  • Industry report
  • March 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Norway diagnostic testing market, including volume and sales forecasts by test for the following market segments:      -  ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.